NRF2-mediated inhibition of alveolar macrophage MHC II expression during Mycobacterium tuberculosis infection
Cell Reports · 2026
DOI: 10.1016/j.celrep.2026.117397 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cell Reports, 2026. Verfasst von Linh K Pham und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Veterinary and Animal Sciences, University of Massachusetts Amherst, Amherst, MA 01003, USA; Animal Biotechnology & Biomedical Sciences…. Hauptthemen laut MEDLINE: NF-E2-Related Factor 2, Macrophages, Alveolar, Mycobacterium tuberculosis, Histocompatibility Antigens Class II. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 115 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIAID NIH HHS, NIGMS NIH HHS, National Institutes of Health.
Abstract (Originalsprache)
During Mycobacterium tuberculosis (Mtb) infection, infected alveolar macrophages (AMs) initially up-regulate a nuclear factor erythroid 2-related factor 2 (NRF2)-regulated cell-protective program, which is detrimental to host control and impedes AM activation, including MHC II expression. MHC II is critical for CD4+ T cell activation and host immunity during Mtb infection. We hypothesized that NRF2 regulates the MHC II pathway and AM antigen presentation to T cells. We found that NRF2 inhibits MHC II, but not MHC I, specifically in AMs, following Mtb infection in vitro and in vivo. NRF2 dampens Ciita and H2-Ab1 gene expression in uninfected AMs, and MHC II inhibition by NRF2 is retained following innate stimuli and IFNγ exposure. NRF2 expression in Mtb-infected AMs impedes their ability to activate ESAT6-specific CD4+ T cells. Thus, although NRF2 expression enhances cell-protective functions, it has the unexpected consequence of limiting innate-adaptive crosstalk, which can impair CD4+ T cell activation and host immunity during Mtb infection.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Veterinary and Animal Sciences, University of Massachusetts Amherst, Amherst, MA 01003, USA; Animal Biotechnology & Biomedical Sciences Graduate Program, University of Massachusetts Amherst, Amherst, MA 01…
- Department of Veterinary and Animal Sciences, University of Massachusetts Amherst, Amherst, MA 01003, USA.
- Department of Veterinary and Animal Sciences, University of Massachusetts Amherst, Amherst, MA 01003, USA; Molecular and Cellular Biology Graduate Program, University of Massachusetts Amherst, Amherst, MA 01003, USA.
- Department of Microbiology, University of Massachusetts Chan Medical School, Worcester, MA 01655, USA.
- Department of Veterinary and Animal Sciences, University of Massachusetts Amherst, Amherst, MA 01003, USA. Electronic address: arothchild@umass.edu.
Förderung
- NIAID NIH HHS
- NIGMS NIH HHS
- National Institutes of Health
- University of Massachusetts Amherst
- University of Massachusetts
- National Institute of Allergy and Infectious Diseases
Zitieren
APA
Pham, L. K., Cervantes, M. M., Lim, P. N., Dubey, D., Tufts, A., Mitchell, M. C., Shinkawa, T., Behar, S. M., & Rothchild, A. C. (2026). NRF2-mediated inhibition of alveolar macrophage MHC II expression during Mycobacterium tuberculosis infection. Cell Reports. https://doi.org/10.1016/j.celrep.2026.117397
Vancouver
Pham LK, Cervantes MM, Lim PN, Dubey D, Tufts A, Mitchell MC, et al. NRF2-mediated inhibition of alveolar macrophage MHC II expression during Mycobacterium tuberculosis infection. Cell Reports. 2026. doi:10.1016/j.celrep.2026.117397
BibTeX
@article{Pham2026,
author = {Pham, Linh K and Cervantes, Maritza M and Lim, Pamelia N and Dubey, Divya and Tufts, Ankita and Mitchell, M Clare and Shinkawa, Tomoyo and Behar, Samuel M and Rothchild, Alissa C},
title = {NRF2-mediated inhibition of alveolar macrophage MHC II expression during Mycobacterium tuberculosis infection},
journal = {Cell Reports},
year = {2026},
doi = {10.1016/j.celrep.2026.117397}
}
EUVIMED